Advanced search
Publication Cover
Cytotherapy Volume 12, 2010 - Issue 5
Journal homepage
15
Views
1
CrossRef citations to date
0
Altmetric
Research Article

A novel cell-based therapy for patients with aplastic anemia

Jiayu Chen Department of Hematology, The 12th Municipal Hospital of Guangzhou, Guangzhou, China
,
Weiwei Liu Department of Hematology, The 12th Municipal Hospital of Guangzhou, Guangzhou, China
,
Wei Yu Department of Hematology, The 12th Municipal Hospital of Guangzhou, Guangzhou, China
,
Lingzhen Chen Department of Hematology, The 12th Municipal Hospital of Guangzhou, Guangzhou, China
,
Jinming Wu Department of Hematology, The 12th Municipal Hospital of Guangzhou, Guangzhou, China
,
Yu Zhan Department of Hematology, The 12th Municipal Hospital of Guangzhou, Guangzhou, China
,
Lupo Wu Zhongxing Yangfan Biotech Co. Ltd, Shenzhen, China
&
Demao Yang Zhongxing Yangfan Biotech Co. Ltd, Shenzhen, ChinaCorrespondence[email protected]
 show all
Pages 678-683 | Received 23 Apr 2009, Accepted 30 Jan 2010, Published online: 29 Apr 2010

References

  • Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136:534–46.
  • Young NS: Drugs and chemicals, Young NS, Alter BP: Aplastic Anemia, Acquired and Inherited, Philadelphia, W.B. Saunders, 1994, 100–32.
  • Deeg HJ, Leisenring W, Storb R, Nims J, Flowers ME, Witherspoon RP, . Long-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91:3637–45.
  • Bacigalupo A, Brand R, Oneto R, Bruno B, Socié G, Passweg J, . Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy. The European Group for Blood and Marrow Transplantation experience. Semin Hematol. 2000;37:69–80.
  • Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058–65.
  • Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, . Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood. 2000;95:1931–4.
  • Dunn DE, Tanawattanacharoen P, Boccuni P, Nagakura S, Green SW, Kirby MR, . Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med. 1999;131:467–8.
  • Socié G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A. Late clonal diseases of treated aplastic anemia. Semin Hematol. 2000;37:91–101.
  • Scheinberg P, Wu CO, Nunez O, Young NS. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol. 2008;144:206–16.
  • Kojima S. Aplastic anemia in the orient. Int J Hematol. 2002;76(Suppl 2):173–4.
  • Young NS, Kaufman SW. The epidemiology of acquired aplastic anemia. Haematologica. 2008;93:489–92.
  • Storb R. Aplastic anemia. J Intraven Nurs. 1997;20: 317–22.
  • Marsh JC, Hows JM, Bryett KA, Al-Hashimi S, Fairhead SM, Gordon-Smith EC. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. Blood. 1987;70:1046–52.
  • Chen J, Liu W, Wang X, Chen H, Wu J, Yang Y, . Ex vivo immunotherapy for patients with benzene-induced aplastic anemia. J Hematother Stem Cell Res. 2003;12:505–14.
  • Li G, Wang X, Wu L, Zhang W, Chen H, Xie Y, . Ex vivo activated immune cells promote survival and stimulate multilineage hematopoietic recovery in myelosuppressed mice. J Immunother 2005;28:420–5.
  • Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, . Severe aplastic anemia: a prospective study on the effect of early marrow transplantation on acute mortality. Blood. 1976;48:63–70.
  • Wimer BM. PHA for aplastic anemias: the alpha but not the omega of mitogen therapies. Cancer Biother Radiopharm. 1998;13:109–20.
  • Catovsky D, Sforza MB. Phytohaemagglutinin in aplastic anemia. Lancet. 1967;4:991–2.
  • Humble JG. In vivo action of phytohaemagglutinin in severe human aplastic anemia. Nature. 1963;198:1313–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.